Proto Script Pharmaceutical

Proto Script Pharmaceutical Net Tangible Assets

The Net Tangible Assets of Proto Script Pharmaceutical (PSCR) as of Nov 1, 2026 is -77,062.00 USD. In the previous year, Net Tangible Assets was 62,242.00 USD — a change of -223.81% (lower).

Net Tangible Assets

-77,062.00USD

YoY

-223.81%

Last updated:

Net Tangible Assets of Proto Script Pharmaceutical is 2016 -77,062.00 USD. Net Tangible Assets of Proto Script Pharmaceutical was 2015 62,242.00 USD. It decreases by -223.81% lower compared to the previous year.

The Proto Script Pharmaceutical Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2014
323,517.00 USD
Jan 1, 2015
62,242.00 USD
Jan 1, 2016
-77,062.00 USD
The Proto Script Pharmaceutical Net Tangible Assets history
YEARNet Tangible AssetsYoY
-77,062.00USD-223.81%
62,242.00USD-80.76%
323,517.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Proto Script Pharmaceutical Stock analysis

What does Proto Script Pharmaceutical do? Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide. Proto Script Pharmaceutical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Proto Script Pharmaceutical stock

Net Tangible Assets of Proto Script Pharmaceutical is -77,062.00 USD in 2016.

Net Tangible Assets of Proto Script Pharmaceutical changed from 62,242.00 USD to -77,062.00 USD, representing a -223.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Proto Script Pharmaceutical since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Proto Script Pharmaceutical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Proto Script Pharmaceutical

All Key Metrics — Proto Script Pharmaceutical